Pharma-Bio Serv (PBSV) Capital Expenditures Growth (1y) (2011 - 2026)
Pharma-Bio Serv (PBSV) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | -70.37% |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 22.19% |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | -0.79% |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | -93.77% |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | -1.75% |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 27,269.64% |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | -32.48% |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | -255.64% |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 | -45.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -45.49% |
| Oct 31, 2025 | -99.78% |
| Jul 31, 2025 | 6.71% |
| Oct 31, 2024 | 10,037.66% |
| Jan 31, 2024 | -89.84% |
| Oct 31, 2023 | -113.02% |
| Apr 30, 2023 | -82.48% |
| Jan 31, 2023 | 1,079.39% |
| Oct 31, 2022 | 1,477.64% |
| Jul 31, 2022 | -70.65% |
| Apr 30, 2022 | 112.94% |
| Jan 31, 2022 | -73.36% |
| Oct 31, 2021 | -113.94% |
| Jul 31, 2021 | -32.04% |
| Apr 30, 2021 | -92.57% |
| Jan 31, 2021 | -77.33% |
| Oct 31, 2020 | -30.79% |
| Jul 31, 2020 | 11.27% |
| Apr 30, 2020 | -22.97% |
| Jan 31, 2020 | 267.37% |